MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/bloodadvances.2018017954

Медицинская библиотека · Blood advances · 2018

Ablation of miR-146b in mice causes hematopoietic malignancy.

Mitsumura Takahiro, Ito Yoshiaki, Chiba Tomoki, Matsushima Takahide, Kurimoto Ryota, Tanaka Yoko, Kato Tomomi, Uchida Keisuke, Ito Takashi, Yamamoto Kouhei, Eishi Yoshinobu, Kitagawa Masanobu, Miyazaki Yasunari, Inase Naohiko, Asahara Hiroshi

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Excessive and constitutive activation of nuclear factor-κB (NF-κB) leads to abnormal cell proliferation and differentiation, leading to the development of malignant tumors, including lymphoma. MicroRNA 146a (miR-146a) and miR-146b, both of which carry an identical seed sequence, have been shown to contribute to inflammatory diseases and tumors by suppressing the expression of key molecules required for NF-κB activation. However, the functional and physiological differences between miR-146a and miR-146b in disease onset have not been fully elucidated. In this study, we generated miR-146b-knockout (KO) and miR-146a-KO mice by genome editing and found that both strains developed hematopoietic malignancies such as B-cell lymphoma and acute myeloid leukemia during aging. However, the B-cell lymphomas observed in miR-146a- and miR-146b-KO mice were histologically different in their morphology, and the malignancy rate is lower in miR-146b mice than miR-146a mice. Upon mitogenic stimulation, the expression of miR-146a and miR-146b was increased, but miR-146b expression was lower than that of miR-146a. Using a previously developed screening system for microRNA targets, we observed that miR-146a and miR-146b could target the same mRNAs, including TRAF6, and inhibit subsequent NF-κB activity. Consistent with these findings, both miR-146a- and miR-146b-KO B cells showed a high proliferative capacity. Taken together, sustained NF-κB activation in miR-146b KO mice could lead to the development of hematopoietic malignancy with aging.

Для цитирования: Mitsumura Takahiro, Ito Yoshiaki, Chiba Tomoki, Matsushima Takahide, Kurimoto Ryota, Tanaka Yoko, Kato Tomomi, Uchida Keisuke, Ito Takashi, Yamamoto Kouhei, Eishi Yoshinobu, Kitagawa Masanobu, Miyazaki Yasunari, Inase Naohiko, Asahara Hiroshi. Ablation of miR-146b in mice causes hematopoietic malignancy.. Blood advances. 2018. DOI: 10.1182/bloodadvances.2018017954.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.